INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 58 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -50.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $4,000 | +33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -40.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $5,000 | +25.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,802,000 | $3,207,000 | 1.13% |
| SENZAR ASSET MANAGEMENT, LLC | 781,922 | $1,392,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 401,764 | $715,000 | 0.10% |
| FT Options LLC | 20,000 | $36,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 367,300 | $654,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,731 | $249,000 | 0.04% |
| FT Options LLC | 14,900 | $7,000 | 0.01% |
| MERIDIAN INVESTMENT COUNSEL INC. | 20,000 | $37,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,500,000 | $2,670,000 | 0.01% |
| Point72 Asset Management, L.P. | 635,465 | $1,131,000 | 0.01% |